Correction to: Improvements in Cognitive Processing Speed, Disability, and Patient‑Reported Outcomes in Patients with Early Relapsing‑Remitting Multiple Sclerosis Treated with Natalizumab: Results of a 4‑year, Real‑World, Open‑Label Study

BACKGROUND: STRIVE was a prospective, 4-year, multicenter, observational, open-label, single-arm study of natalizumab treatment in anti-JC virus antibody-negative patients with early relapsing-remitting multiple sclerosis (RRMS). OBJECTIVE: Study objectives examined the effects of natalizumab on cog...

Descripción completa

Detalles Bibliográficos
Autores principales: Perumal, Jai, Balabanov, Roumen, Su, Ray, Chang, Roger, Balcer, Laura J., Galetta, Steven L., Avila, Robin L., Rutledge, Danette, Fox, Robert J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024661/
https://www.ncbi.nlm.nih.gov/pubmed/36780107
http://dx.doi.org/10.1007/s40263-022-00982-6

Ejemplares similares

Ejemplares similares